Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmablast Trafficking and Antibody Response in Influenza Vaccination
NCT02141581Phase 4Completed
- Sponsor
- Stanford University
- Start
- Aug 2011
- Primary completion
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Fluzone Trivalent and live attenuated influenza vaccine in influenza (3 arms), sponsored by Stanford University. Primary endpoint: Number of Participants From Each Arm Who Received Influenza Vaccine at Day 28. Started Aug 2011; status: completed.
02
Drugs
Fluzone Trivalentlive attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02141581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141581.